×
Sanofi Revenue 2010-2025 | SNY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Sanofi revenue for the twelve months ending March 31, 2025 was
$47.024B
, a
7.21% decline
year-over-year.
Sanofi annual revenue for 2024 was
$47.922B
, a
4.66% decline
from 2023.
Sanofi annual revenue for 2023 was
$50.266B
, a
5.11% increase
from 2022.
Sanofi annual revenue for 2022 was
$47.822B
, a
3.18% increase
from 2021.
View More
Sanofi Revenue 2010-2025 | SNY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Sanofi annual revenue for 2024 was
$47.922B
, a
4.66% decline
from 2023.
Sanofi annual revenue for 2023 was
$50.266B
, a
5.11% increase
from 2022.
Sanofi annual revenue for 2022 was
$47.822B
, a
3.18% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$796.4B
Johnson & Johnson (JNJ)
$379.5B
AbbVie (ABBV)
$306B
Novo Nordisk (NVO)
$260.6B
Roche Holding AG (RHHBY)
$248.1B
Novartis AG (NVS)
$234.2B
Merck (MRK)
$196.7B
Pfizer (PFE)
$125.6B
Bayer (BAYRY)
$23.7B
Innoviva (INVA)
$1.1B